Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 31, 1999 - Issue 6
Submit an article Journal homepage
319
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Pathogenic Mechanism of Acute Post-Streptococcal Glomerulonephritis

Annika Nordstrand, Mari Norgren, Stigt E. Holm Department of Clinical Bacteriology, UmeåUniversity, SE-90185 Umeå, Sweden
Pages 523-537 | Published online: 08 Jul 2009

  • Sorger K. Pathomorphological findings. In: Sorger K, ed. Postinfectious glomerulonephritis. Subtypes, clinico-pathological correlations, and follow-up studies. Stuttgart: Gustav Fischer Verlag, 1986: 15–19.
  • Stetson GA, Rammelkamp CH, Krause RM, Kohen RJ, Perry WD. Epidemic acute nephritis: studies on etiology, natural history and prevention. Medicine 1955; 34: 431.
  • Keller CK, Andrassy K, Waldherr R, Ritz E. Postinfectious glomerulonephritis – is there a link to alcoholism? Q J Med 1994; 87: 97–102.
  • Garrett PJ, Bass PS, Atchley JT, Theaker JM, Dathan JR. Wegener’s granulomatosis and acute poststreptococcal glomerulonephritis. Nephrol Dial Transplant 1993; 8: 454–5.
  • Hiki Y, Tamura K, Shigematsu H, Kobayashi Y. Superimposition of poststreptococcal glomerulonephritis on the course of IgA nephropathy. Nephron 1991; 57: 358–64.
  • Okada K, Saitoh S, Sagaguchi Z, Zhang RJ, Kuhara T, Yasutomo K, et al. IgA nephropathy presenting clinicopathological features of acute post-streptococcal glomerulonephritis. Eur J Pediatr 1996; 155: 327–30.
  • Chihara J, Takebayashi S, Taguchi T, Yokohama K, Harada T, Naito S. Glomerulonephritis in diabetic patients and its effect on the prognosis. Nephron 1986; 43: 45–9.
  • Lévy M. Infections and glomerular diseases. Clin Immunol Allergy 1986; 6: 255–85.
  • Haase A, Melder A, Kemp D, Mathews J. Streptokinase alleles and disease association in group A streptococci. FEMS Immunol Med Microbiol 1994; 10: 75–80.
  • Streeton CL, Hanna JN, Messer RD, Merianos A. An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children. J Pediatr Child Health 1995; 31: 245–8.
  • Parker MT. Streptococcal skin infection and acute glomerulo-nephritis. Br J Dermatol 1969; 81: 37–46.
  • Bergholm A-M, Holm SE. Experimental poststreptococcal glomerulonephritis in rabbits. Acta Path Microbiol Immunol Scand Sect C 1983; 91: 263–70.
  • Burova LA, Nagornev VA, Pigarevsky PV, Gladilina MM, Seliverstova VG, Schalén C, et al. Triggering of renal tissue damage in the rabbit by IgG Fc-receptor-positive group A streptococci. APMIS 1998; 106: 277–87.
  • Cronin WJ, Lange K. Immunologic evidence for the in situ deposition of a cytoplasmic streptococcal antigen (endostreptosin) on the glomerular basement membrane in rats. Clin Nephrol 1990; 34: 143–6.
  • Michael AF, Hoyer JR, Westberg NG, Fish AJ. Experimental models for the pathogenesis of acute poststreptococcal glomerulonephritis. In: Wannamaker LW, Matsen LJ, eds. Streptococci and streptococcal diseases. Recognition, understanding, and management. New York: Academic Press, 1972: 481–96.
  • Peake PW, Pussell BA, Karplus TE, Riley EH, Charlesworth JA. Post-streptococcal glomerulonephritis: studies on the interaction between nephritis strain-associated protein (NSAP), complement and the glomerulus. APMIS 1991; 99: 460–6.
  • Yoshizawa N, Oshima S, Takeuchi A, Kondo S, Oda T, Shimizu J, et al. Experimental acute glomerulonephritis induced in the rabbit with a specific streptococcal antigen. Clin Exp Immunol 1996; 107: 61–7.
  • Nordstrand A, Norgren M, Holm SE. An experimental model for acute poststreptococcal glmerulonephritis in mice. APMIS 1996; 104: 805–16.
  • Nordstrand A, Norgren M, Ferretti JJ, Holm SE. Streptokinase as a mediator of acute post-streptococcal glomerulonephritis in an experimental mouse model. Infect Immun 1998; 66: 315–21.
  • Rammelkamp CH, Weaver RS. Acute glomerulonephritis. The significance of the variation in the incidence of the disease. J Clin Invest 1953; 32: 346–58.
  • Poon-King T, Mohammed I, Cox R, Potter EV, Simon NM, Siegel AC, et al. Recurrent epidemic nephritis in South Trinidad. N Engl J Med 1967; 277: 728–33.
  • Wannamaker LW. Differences between streptococcal infections of the throat and of the skin. N Engl J Med 1970; 282: 78–85.
  • Barnham M, Thornton TJ, Lange K. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C). Lancet 1983; 1: 945–8.
  • Grann JW, Gray BM, Griffin FM, Dismuke WE. Acute glomerulonephritis following group G streptococcal infection. J Infect Dis 1987; 156: 411–2.
  • Duca E, Teodorovici G, Radu C, Vita A, Talasman-Niculescu P, Bernescu E, et al. A new nephritogenic streptococcus. J Hyg (Lond) 1969; 67: 691–8.
  • Reid HF, Bassett DC, Poon-King T, Zabriskie JB, Read SE. Group G streptococci in healthy school children and in patients with glomerulonephritis in Trinidad. J Hyg (Lond) 1985; 94: 61–8.
  • Tewodros W, Muhe L, Daniel E, Schalén C, Kronvall G. A one-year study of streptococcal infections and their complications among Ethiopian children. Epidemiol Infect 1992; 109: 211–25.
  • Onyewotu II, Mee J. Circulating immune complexes and complement levels in relation to the clinical presentation of Nigerian children with acute poststreptococcal glomerulonephritis. J Clin Pathol 1978; 31: 817–22.
  • Hallett AF, Adhikari M, Cooper R, Coovadia HM. Post-streptococcal glomerulonephritis in African children. Trans R Soc Trop Med Hyg 1977; 71: 241–6.
  • Leung DT, Tseng RY, Go SH, French GL, Lam CW. Post-streptococcal glomerulonephritis in Hong Kong. Arch Dis Child 1987; 62: 1075–6.
  • Rodriguez-Iturbe B, Garcia R, Rubio L, Cuenca L, Treser G, Lange K. Epidemic glomerulonephritis in Maracaibo: evidence for progression to chronicity. Clin Nephrol 1976; 5: 197–206.
  • Anthony BF, Kaplan EL, Wannamaker LW, Briese FW, Chapman SS. Attack rates of acute nephritis after type-49 streptococcal infection of the skin and of the respiratory tract. J Clin Invest 1969; 48: 1697–704.
  • Kaplan EL, Anthony BF, Chapman SS, Wannamaker LW. Epidemic acute glomerulonephritis associated with type 49 streptococcal pyoderma. I. Clinical and laboratory findings. Am J Med 1970; 48: 9–27.
  • Reinstein CR. Epidemic outbreaks at Red Lake, Minnesota. J Pediatr 1955; 47: 25.
  • Zimmerman R, Cross M, Miller DR, Sciple GW. A streptococcal epidemic in an isolated civilian population with institution of mass profylaxis. J Pediatr 1966; 69: 40–5.
  • Baldwin DS, Gluck MC, Schacht RG, Gallo G. The long term course of poststreptococcal glomerulonephritis. Ann Intern Med 1974; 80: 342–58.
  • Layrisse Z, Rodriguez-Iturbe B, Garcia-Ramirez R, Rodriguez A, Tiwari J. Family studies of the HLA system in acute post-streptococcal glomerulonephritis. Human Immunology 1983; 7: 177–85.
  • Anthony BF, Kaplan EL, Chapman SS, Quie PG, Wanna-maker LW. Epidemic acute nephritis with reappearance of type-49 streptococcus. Lancet 1967; 2: 787.
  • Nordstrand A. Acute post-streptococcal glomerulonephritis and streptokinase. Doctoral thesis, Umeå University, Sweden, 1998.
  • Seligson G, Lange K, Majeed HA, Deol HL, Cronin W, Boyle R. Significance of endostreptosin antibody titers in poststreptococcal glomerulonephritis. Clin Nephrol 1985; 24: 69–75.
  • Yoshizawa N, Oshima S, Sagel I, Shimizu J, Treser G. Role of a streptococcal antigen in the pathogenesis of acute post-streptococcal glomerulonephritis. Characterization of the antigen and a proposed mechanism for the disease. J Immunol 1992; 148: 3110–6.
  • Ohkuni H, Friedman J, Van de Rijn I, Fischetti VA, Poon-King T, Zabriskie JB. Immunological studies of poststreptococcal sequelae: serological studies with an extracellular protein associated with nephritogenic streptococci. Clin Exp J Med 1983; 54: 185–93.
  • Cu GA, Mezzano S, Zabriskie JB. Role of a streptococcal proteinase in acute post-streptococcal glomerulonephritis. Adv Exp Med Biol 1997; 418: 137–40.
  • Cu GA, Mezzano S, Bannan JD, Zabriskie JB. Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis. Kidney Int 1998; 54: 819–26.
  • Mezzano S, Burgos E, Mahabir R, Kemeney E, Zabriskie JB. Failure to detect unique reactivity to streptococcal streptokinase in either the sera or renal biopsy specimens of patients with acute poststreptococcal glomerulonephritis. Clin Nephrol 1992; 38: 305–10.
  • Tewodros W, Norgren M, Kronvall G. Streptokinase activity among group A streptococci in relation to streptokinase genotype, plasminogen binding, and disease manifestations. Microb Pathog 1995; 18: 53–65.
  • Norrby-Teglund A, Pauksens K, Holm SE, Norgren M. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestations of disease. J Infect Dis 1994; 170: 585–91.
  • Endre ZH, Pussell BA, Charlesworth JA, Coovadia HM, Seedat YK. C3 metabolism in acute glomerulonephritis: Implications for sites of complement activation. Kidney Int 1984; 25: 937–41.
  • Parra G, Platt JL, Falk RJ, Rodriguez-Iturbe B, Michael AF. Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: Identification using monoclonal antibodies by indirect immunofluorescence. Clin Immunol Immunopathol 1984; 33: 324–32.
  • Rastaldi MP, Ferrario F, Yang L, Tunesi S, Indaco A, Zhou H, et al. Adhesion molecules expression in noncrescentic acute post-streptococcal glomerulonephritis. J Am Soc Nephrol 1996; 7: 2419–27.
  • Pirani CL. Evaluation of kidney biopsy specimens. In: Tischer CC, Brenner BM, eds. Renal pathology with clinical and functional correlations. Philadelphia: JB Lippincott Co, 1989: 12.
  • Fairley C, Mathews DC, Becker GJ. Rapid development of diffuse crescents in poststreptococcal glomerulonephritis. Clin Nephrol 1987; 28: 256–60.
  • Edelstein CL, Bates WD. Subtypes of acute postinfectious glomerulonephritis: a clinico-pathological correlation. Clin Nephrol 1992; 38: 311–7.
  • Brentjens JR, Milgrom ML, Andrews GA. Classification and immunopathologic features of human nephritis. In: Wilson CB, Brenner BM, Stein JH, eds. Contemporary issues in nephrology. New York: Churchill Livingstone, 1979; 3: 214– 254
  • Gewurtz H, Ying SC, Jiang H, Lint TF. Nonimmune activation of the classical complement pathway. Behring Inst Mitt 1993; 93: 138–47.
  • Gewurz H, Pickering RJ, Good RA. Complement and complement component activities in diseases associated with repeated infections and malignancy. Int Arch Appl Immunol 1968; 33: 368–88.
  • Sjöholm AG, Sturfelt G. Cleavage of C2 in pathological serum and plasma studied by crossed immunoelectrophoresis. Acta Pathol Microbiol Immunol Scand 1984; 92: 265–9.
  • Kefalides NA, Pegg T, Ohno N, Poon-King T, Zabriskie JB, Fillit H. Antibodies to basement membrane collagen and to laminin are present in sera from patients with poststreptococcal glomerulonephritis. J Exp Med 1986; 163: 588–602.
  • Rodriguez-Iturbe B, Carr RI, Garcia R, Rabideau D, Rubio L, McIntosh RM. Circulating immune complexes and serum immunoglobulins in acute poststreptococcal glomerulonephritis. Clin Nephrol 1980; 13: 1–4.
  • Mezzano S, Olavarria F, Ardiles L, Lopez MI. Incidence of circulating immune complexes in patients with acute post-streptococcal glomerulonephritis and in patients with streptococcal impetigo. Clin Nephrol 1986; 26: 61–5.
  • Yoshizawa N, Treser G, McClung JA, Sagel I, Takahashi K. Circulating immune complexes in patients with uncomplicated group A streptococcal pharyngitis and patients with acute poststreptococcal glomerulonephritis. Am J Nephrol 1983; 3: 23–9.
  • Van de Rijn I, Fillit H, Brandeis WE, Reid H, Poon-King T, McCarthy M, et al. Serial studies on circulating immune complexes in post-streptococcal sequelae. Clin Exp Immunol 1978; 34: 318–25.
  • Holm SE. The pathogenesis of acute post-streptococcal glomerulonephritis in new lights. APMIS 1988; 96: 189–93.
  • Matsell DG, Wyatt RJ, Gaber LW. Terminal complement complexes in acute poststreptococcal glomerulonephritis. Pediatr Nephrol 1994; 8: 671–6.
  • Matsell DG, Roy S, Tamerius JD, Morrow PR, Kolb WP, Wyatt RJ. Plasma terminal complement complexes in acute poststreptococcal glomerulonephritis. Am J Kidney Dis 1991; 17: 311–6.
  • Ohta K, Takano N, Seno A, Yachie A, Miyawaki T, Yokoyama H, Tomosugi N, Kato E, Taniguchi N. Detection and clinical usefulness of urinary interleukin-6 in the diseases of the kidney and urinary tract. Clin Nephrol 1992; 38: 185–9.
  • Wada T, Yokoyama H, Tomosugi N, Hisada Y, Ohta S, Naito T, Kobayashi K, Mukaida N, Matsushima K. Detection of urinary interleukin-8 in glomerular diseases. Kidney Int 1994; 46: 455–60.
  • Rosenberg HG, Donoso PL, Via SU, Carranza C, Romero P. Clinical and morphological recovery between two episodes of acute glomerulonephritis: a light and elctron microscopy study with immunofluorescence. Clin Nephrol 1984; 21: 350– 4.
  • Vogl W, Renke M, Mayer-Eichberger D, Schmitt H, Bohle A. Long-term prognosis for endocapillary glomerulonephritis of poststreptococcal type in children and adults. Nephron 1986; 44: 58–65.
  • Schacht RG, Gluck MC, Gallo GR, Baldwin DS. Progression to uremia after remission of acute poststreptococcal glomerulonephritis. N Engl J Med 1976; 295: 977–81.
  • Rodriguez-Iturbe B, Castillo L, Valbuena R, Cuenca L. Attack rate of poststreptococcal nephritis in families: a prospective study. Lancet 1981; 1: 401–3.
  • Sagel I, Treser G, Ty A, Yoshizawa N, Kleinberger H, Yuceoglu AM, et al. Occurrence and nature of glomerular lesions after group A streptococcal infections in children. Ann Intern Med 1973; 79: 492–9.
  • Yoshizawa N, Suzuki Y, Oshima S, Takeuchi A, Kondo S, Ishida A, et al. Asymptomatic acute poststreptococcal glomerulonephritis following upper respiratory tract infections caused by group A streptococci. Clin Nephrol 1996; 46: 296–301.
  • Burova LA, Koroleva IV, Ogurtzov RP, Murashov SV, Svensson ML, Schalén C. Role of streptococcal IgG receptor in tissue deposition of IgG in rabbits immunized with Streptococcus pyogenes. APMIS 1992; 100: 567–74.
  • Batsford SR. Cationic antigens as mediators of inflammation. APMIS 1991; 99: 1–9.
  • Dixon FJ, Wilson CB. Immunological renal injury produced by formation and deposition of immune complexes. In: Wilson CB, Brenner BM, Stein JH, eds. Immunologic mechanisms of renal disease. London: Churchill Livingstone, 1979: 12.
  • Efstratiou A, Teare EL, McGhie D, Colman G. The presence of M proteins in outbreak strains of Streptococcus equisimilis T-type 204. J Infect 1989; 19: 105–11.
  • Collins CM, Kimura A, Bisno AL. Group G streptococcal M protein exhibits structural features analogous to those of class 1 M protein of group A streptococci. Infect Immun 1992; 60: 3689–96.
  • Lancefield RC. Current knowledge of type-specific M antigens of group A streptococci. J Immunol 1962; 89: 307–13.
  • Phillips GN, Flicker PF, Cohen C, Manjula BN, Fischetti VA. Streptococcal M protein: -helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci 1981; 78: 4689–93.
  • Manjula BN, Acharya AS, Mische SM, Fairwell T, Fischetti VA. The complete amino acid sequence of a biologically active 197-residue fragment of M protein from type 5 group A streptococci. J Biol Chem 1984; 259: 3686–93.
  • Khandke KM, Fairwell T, Manjula BN. Difference in the structural features of streptococcal M proteins from nephritogenic and rheumatogenic serotypes. J Exp Med 1987; 166: 151–62.
  • Mori K, Ito Y, Kamikawaji N, Sasazuki T. Elevated titer against the C region of streptococcal M protein and its immunodeterminants in patients with poststreptococcal acute glomerulonephritis. J Pediatr 1997; 131: 293–9.
  • Kantor FS. Fibrinogen precipitation by streptococcal M protein: II. Renal lesions induced by intravenous injection of M protein into mice and rats. J Exp Med 1965; 121: 849.
  • Humair L, Potter EV, Kwan HC. The role of fibrinogen in renal disease: production of experimental lesions in mice. J Lab Clin Med 1969; 74: 60–71.
  • Markowitz AS, Lange CF. Streptococcal related glomerulonephritis: I. Isolation, immunocytochemistry and comparative chemistry of soluble fractions from type 12 nephritogenic streptococci and human glomeruli. J Immunol 1964; 92: 565.
  • Glurich I, Winters B, Albini B, Stinson M. Identification of Streptococcus pyogenes proteins that bind to rabbit kidney in vitro and in vivo. Microb Pathog 1991; 10: 209–20.
  • Kehoe MA. Cell-wall-associated proteins in Gram-positive bacteria. New Comph Biochem 1994; 27: 217–61.
  • Tewodros W, Kronvall G. Distribution of presumptive pathogenicity factors among beta-hemolytic streptococci isolated from Ethiopia. APMIS 1993; 101: 295–305.
  • Christensen P, Sjöholm AG, Holm SE, Hovelius B, Mårdh PA. Binding of aggregated IgG in the presence of fresh serum by group A streptococci producing pharyngeal infection: possible connection with types frequently involved in acute nephritis. Acta Pathol Microbiol Scand Sect B 1978; 86: 29–33.
  • Schalén C, Christensen P, Kurl D, Sramek J, Svensson M-L. Interaction of nephritis-associated group A streptococci with aggregated human IgG. In: Kimura Y, Kotami S, Shiokawa S, eds. Recent advances in streptococci and streptococcal diseases. Chertsey, Surrey: Reedbooks Ltd, 1985: 81–3.
  • Cleary PP, Retnoningrum D. Group A streptococcal immunoglobulin-binding proteins: adhesins, molecular mimicry or sensory proteins? Trends Microbiol 1994; 2: 131–6.
  • Frithz E, Hedén LO, Lindahl G. Extensive sequence homology between IgA receptor and M proteins in Streptococcus pyogenes. Mol Microbiol 1989; 3: 9–11.
  • Heath DG, Cleary PP. Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci USA 1989; 86: 4741–5.
  • Kronvall G. A surface component in group A, G, and C streptococci with nonimmune reactivity for immunogobulin G. J Immunol 1973; 111: 1401–6.
  • Kronvall G, Simmons A, Myhre EB, Jonsson S. Specific absorption of human serum albumin, immunoglobulin A, and immunoglobulin G with selected strains of group A and G streptococci. Infect Immun 1979; 25: 1–10.
  • Lindahl G, Stenberg L. Binding of IgA and/orIgG is a common property among clinical isolates of group A streptococci. Epidemiol Infect 1990; 105: 87–93.
  • Bessen DE, Fischetti VA. Nucleotide sequence of two adjacent M or M-like proteins genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect Immun 1992; 60: 124–35.
  • Boyle MDP, Hawlitzky J, Raeder R, Podbielski A. Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun 1994; 62: 1336–47.
  • Podbielski A, Hawlitzky J, Pack TD, Flosdorff A, Boyle MDP. A group A streptococcal protein potentially resulting from intergenomic recombination exhibits atypical immunoglobulin-binding characteristics. Mol Microbiol 1994; 12: 725–36.
  • Retnoningrum DS, Podbielski A, Cleary PP. Type M12 protein from Streptococcus pyogenes is a receptor for IgG3. J Immunol 1993; 150: 2332–3240.
  • Stenberg L, OTToole P, Lindahl G. Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type. Mol Microbiol 1992; 6: 1185–94.
  • Stenberg L, O’Toole P, Mestecky J, Lindahl G. Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J Biol Chem 1994; 269: 13458–64.
  • Åkesson P, Cooney J, Kishimoto F, Björck L. Protein H – a novel IgG binding bacterial protein. Mol Immunol 1990; 6: 523–31.
  • Myhre E, Kronvall G. Heterogeneity of non-immune immunogobulin Fc reactivity among gram-positive cocci: Description of three major types of receptors for human immunogobulin G. Infect Immun 1977; 17: 475–82.
  • McIntosh RM, Garcia R, Rubio L, Rabideau D, Allen JE, Carr RI, et al. Evidence of an autologous immune complex pathogenic mechanism in acute poststreptococcal glomerulonephritis. Kidney Int 1978; 14: 501–10.
  • Mosquera JA, Rodriguez-Iturbe B. Extracellular neuraminidase production of streptococci with acute nephritis. Clin Nephrol 1984; 21: 21–8.
  • Potter EV, Shaugnessy MA, Poon-King T, Earle DP. Streptococcal neuraminidase and acute glomerulonephritis. Infect Immun 1982; 38: 1196–202.
  • Lange K, Ahmed U, Kleinberger H, Treser G. A hitherto unknown antigen and its probable relation to acute poststreptococcal glomerulonephritis. Clin Nephrol 1976; 5: 207–15.
  • Lange K, Seligson G, Cronin W. Evidence for the in situ origin of poststreptococcal GN: Glomerular localization of endostreptosin and the clinical significance of the subsequent antibody response. Clin Nephrol 1983; 19: 3–10.
  • Yoshizawa N, Treser G, Sagel I, Ty A, Ahmed U, Lange K. Demonstration of antigenic sites in glomeruli of patients with acute poststreptococcal glomerulonephritis by immunofluorescein and immunoferritin technics. Am J Pathol 1973; 70: 131–50.
  • Yoshizawa N, Treser G, Iwasaki M, Takahashi K. Further characterization of a streptococcal antigen in acute glomerulonephritis. In: Holm SE, Christensen P, eds. Basic concepts of streptococci and streptococcal diseases. Windsor: Reed-book Ltd, 1982: 257–9.
  • Stinson MW, McLaughlin R, Choi SH, Juarez ZE, Barnard J. Streptococcal histone-like protein: primary structure of hlpA and protein binding to lipoteichoic acid and epithelial cells. Infect Immun 1998; 66: 259–65.
  • Vogt A, Batsford S, Rodriguez-Iturbe B, Garcia R. Cationic antigens in poststreptococcal glomerulonephritis. Clin Nephrol 1983; 20: 271–9.
  • Villareal H Jr, Fischetti VA, Van de Rijn I, Zabriskie JB. The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis. J Exp Med 1979; 149: 459–72.
  • Johnston KH, Zabriskie JB. Purification and partial characterization of the nephrits strain-associated protein from Streptococcus pyogenes. J Exp Med 1986; 163: 697–712.
  • Poon-King R, Bannan J, Viteri A, Cu G, Zabriskie JB. Identification of an extracellular plasmin binding protein from nephritogenic streptococci. J Exp Med 1993; 178: 759– 63.
  • Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8: 411–26.
  • Kapur V, Malesky MW, Li L-L, Black RA, Musser JM. Cleavage of interleukin 1 (IL-1 ) precursor to produce active IL-1 by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 1993; 90: 7676–80.
  • Kapur V, Topouzis S, Majesky MW, Li L-L, Hamrick MR, Hamill LJ, et al. A conserved Streptococcus pyogenes extra-cellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathogen 1993; 15: 327–46.
  • Herwald H, Collin M, Mu¨ller-Esterl W, Björck L. Streptococcal cysteine protease releases kinins: a novel virulence mechanism. J Exp Med 1996; 184: 665–73.
  • Berge A, Björck L. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 1995; 270: 9862–7.
  • Yu CE, Ferretti JJ. Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci. Infect Immun 1991; 59: 211–5.
  • Chaussee MS, Liu J, Stevens DL, Ferretti JJ. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996; 173: 901–8.
  • Lukomski S, Sreevatsan S, Amberg C, Reichardt W, Woischnik M, Podbielsky A, et al. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreased mouse lethality of serotype M3 and M49 strains. J Clin Invest 1997; 99: 2574–80.
  • Huang TT, Malke H, Ferretti JJ. Heterogeneity of the streptokinase gene in group A streptococci. Infect Immun 1989; 57: 502–6.
  • Huang TT, Malke H, Ferretti JJ. The streptokinase gene of group A streptococci: cloning, expression in Escherichia coli, and sequence analysis. Mol Microbiol 1989; 3: 197–205.
  • Frank C, Steiner K, Malke H. Conservation of the organization of the streptokinase gene region among pathogenic streptococci. Med Microbiol Immunol 1995; 184: 139–46.
  • Johnston KH, Chaiban JE, Wheeler RC. Analysis of the variable domain of the streptokinase gene from streptococci associated with post streptococcal glomerulonephritis. In: Orefici G, ed. New perspectives on streptococci and streptococcal infections. Stuttgart: Gustav Fischer Verlag, 1992: 339–41.
  • Wheeler RC, Chaiban JE, Johnston KH. Analysis of the streptokinase gene from group C streptococci S. equisimilis and S. zooepidemicus by the polymerase chain reaction and possible relation to poststreptococcal glomerulonephritis. In: Orefici G, ed. New perspectives on streptococci and streptococcal infections. Stuttgart: Gustav Fischer Verlag, 1992: 343–5.
  • Johnston KH, Chaiban JE, Wheeler RC. Analysis of the variable domain of the streptokinase gene from group A streptococci by the polymerase chain reaction. In: Cleary P, Dunny, eds. Streptococcal genetics. Washington DC: ASM Publications, 1991: 190–4.
  • Malke H. Polymorphism of the streptokinase gene: implications for the pathogenesis of post-streptococcal glomerulonephritis. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 278: 246–57.
  • Kapur V, Kanjilal S, Hamrick MR, Li L-L, Whittam TS, Sawyer SA, et al. Molecular population genetic analysis of the streptokinase gene of Streptococcus pyogenes: mosaic alleles generated by recombination. Mol Microbiol 1995; 16: 509–19.
  • Wefle K, Misselwitz R, Schaup A, Gerlach D, Wefle H. Conformation and stability of streptokinases from nephritogenic and non-nephritogenic strains of streptococci. Proteins: Structure, Function and Genetics 1997; 27: 26–35.
  • Tewodros W, Nordstrand A, Kronvall G, Holm SE, Norgren M. Streptokinase gene polymorphism in group A streptococci isolated from Ethiopian children with various disease manifestations. Microb Pathog 1993; 15: 303–11.
  • Okada K, Katano T, Kamogashira T, Zahn RJ, Morimito Y, Kagami S, Yasimoto K, Kuhara T, Kuroda Y. Streptokinase gene variable region classification in streptococci: lack of correlation with post-streptococcal glomerulonephritis. Clin Nephrol 1995; 44: 8–13.
  • Haase AM, Melder A, Mathews JD, Kemp DJ, Adams M. Clonal diversity of Streptococcus pyogenes within some M-types revealed by multilocus enzyme electrophoresis. Epidemiol Infect 1994; 113: 455–62.
  • Lottenberg R. A novel approach to explore the role of plasminogen in bacterial pathogenesis. Trends Microbiol 1997; 5: 466–7.
  • Miles LA, Plow EF. Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis. Fibrinolysis 1988; 2: 61–71.
  • Kuusela P, Saksela O. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Increase in affinity after conversion to the Lys form of the ligand. Eur J Biochem 1990; 193: 759–65.
  • Kuusela P, Ullberg M, Saksela O, Kronvall G. Tissue-type plasminogen activator-mediated activation of plasminogen on the surface of group A, C, and G streptococci. Infect Immun 1992; 60: 196–201.
  • Berge A, Sjöbring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem 1993; 268: 25417–24.
  • Ringdahl U, Svensson M, Wistedt AC, Renn T, Kellner R, Muller-Esterl W, et al. Molecular co-operation between protein PAM and streptokinase for plasmin acquisition by Streptococcus pyogenes. J Biol Chem 1998; 273: 6424–30.
  • Ullberg M, Kronvall G, Wiman B. New receptor for human plasminogen on gram positive cocci. APMIS 1989; 97: 996– 1002.
  • Lähteenmäki K, Virkola R, Pouttu R, Kuusela P, Kukkonen M, Korhonen TK. Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix. Infect Immun 1995; 63: 3659–64.
  • Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science 1992; 258: 1004–7.
  • Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997; 89: 1111–9.
  • Coleman JL, Sellati TJ, Testa JE, Kew RR, Furie MB, Benach JL. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect Immun 1995; 63: 2478–84.
  • Castellino FJ, Bajaj SP. Activation of human plasminogen by equimolar levels of streptokinase. J Biol Chem 1977; 252: 492–8.
  • Grella DK, Castellino FJ. Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur. Blood 1997; 89: 1585–9.
  • Cederholm-Williams SA, De Cock F, Lijnen DR, Collen D. Kinetics of the reactions between streptokinase, plasmin and α2-antiplasmin. Eur J Biochem 1979; 100: 125–32.
  • Davies MC, Englert ME, De Renzo EC. Interaction of streptokinase and human plasminogen. I. Combining of streptokinase and plasminogen observed in the ultracentrifuge under a variety of experimental conditions. J Biol Chem 1964; 239: 2651–6.
  • Collen D, Van Hoef B, Schlott B, Hartmann M, Guhrs KH, Lijnen HR. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase. Eur J Biochem 1993; 216: 307–14.
  • Malke H, Roe B, Ferretti JJ. Nucleotide sequence of the streptokinase gene from Streptococcus equisimilis H46A. Gene 1985; 34: 357–62.
  • Silence K, Collen D, Lijnen HR. Regulation by 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma. Blood 1993; 82: 1175–83.
  • Wulf RJ, Mertz ET. Studies on plasminogen. VIII. Species specificity of streptokinase. Can J Biochem 1968; 47: 927–31.
  • Werb Z, Mainardi CL, Vater CA, Harris ED Jr. Endogenous activation of latent collagenase by rheumatoid synovial cells: Evidence for a role of plasminogen activator. N Engl J Med 1977; 296: 1017–23.
  • He CS, Wilhelm SM, Pentland AP, Marmer BL, Grat GA, Eisen AZ, et al. Tissue co-operation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86: 2632–6.
  • Bennett WR, Yawn DN, Migliore PJ, Young JB, Pratt CM, Raizner AE, et al. Activation of the complement system by recombinant tissue plasminogen activator. J Am Coll Cardiol 1987; 10: 627–32.
  • Kirschfink M, Borsos T. Binding and activation of C4 and C3 on the red cell surface by non-complement enzymes. Mol Immunol 1988; 25: 505–12.
  • Ewald GA, Eisenberg PR. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis. Circulation 1995; 91: 28–36.
  • Ghebrehiwet B, Silverberg M, Kaplan AP. Activation of the classical pathway of complement by Hageman factor fragment. J Exp Med 1981; 153: 665–76.
  • Kehoe MA, Kapur V, Whatmore AM, Musser JM. Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology. Trends Microbiol 1996; 4: 436–43.
  • Single LA, Martin DR. Clonal difference within M types of the group A streptococcus revealed by pulsed field gel electrophoresis. FEMS Microbiol Lett 1992; 91: 85–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.